ANZ takes $22m stake in Pacific Edge

ANZ takes $22m stake in Pacific Edge
Dan Brunskill
ANZ New Zealand Investments has bought $22 million of new shares in cancer diagnostics company Pacific Edge at a premium. Pacific Edge will issue 33.8 million shares to ANZ at 65 cents per share, a 14 percent premium to the volume weighted average share price over the previous 5-day trading period. The company currently has more than 689 million shares on issue.  The share price jumped 17.24 percent to 68 cents in early trading, up 467 percent year-to-date. The investment from ANZ follows Pacific Edge’s breakthrough in the United State...